Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
405
-
Total 13F shares, excl. options
-
227,000,681
-
Shares change
-
+2,610,786
-
Total reported value, excl. options
-
$21,491,265,738
-
Value change
-
+$278,089,765
-
Put/Call ratio
-
1.01%
-
Number of buys
-
184
-
Number of sells
-
-200
-
Price
-
$94.68
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2014
489 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q2 2014.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 405 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 227,000,681 shares
of 256,606,920 outstanding shares and own 88.46% of the company stock.
Largest 10 shareholders include Capital World Investors (26,382,177 shares), VANGUARD GROUP INC (16,702,746 shares), WELLINGTON MANAGEMENT CO LLP (16,461,104 shares), PRICE T ROWE ASSOCIATES INC /MD/ (13,866,784 shares), FMR LLC (13,026,543 shares), JENNISON ASSOCIATES LLC (11,865,009 shares), State Street Corp (9,961,924 shares), JPMORGAN CHASE & CO (9,635,998 shares), Clearbridge Investments, LLC (7,549,418 shares), and Ameriprise Financial Inc (7,078,575 shares).
This table shows the top 405 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.